Help Defeat Aging 🎶

Bryan Johnson will become immortal by 2039. At 48, he spent $2M/year reversing aging, his biological age is clinically measured at 18 and erectile health is better than 99% of 22 year-old. Here's his evidence-based longevity blueprint (& how to use it yourself):

⚡️ NOW: OpenAI introduces a new update to GPT-Rosalind, its life sciences model, bringing GPT-5.5 agentic capabilities for drug discovery and genomics research.

LATEST: ⚡️ Brian Armstrong's anti-aging biotech Newlimit raised $435M in a Series C, tripling its valuation to $3.1B, and plans to start human trials next year.

NEW: Coinbase founder Brian Armstrong’s longevity startup NewLimit has tripled in value to $3,100,000,000.00.

Longevity is about to absolutely dominate the medical field once you can you prevent the disease, the entire model shifts

It's gotta be a good sign for humanity that the longevity company just collected all the vc infinity stones.

The path to achieve longevity escape velocity is open; the question is no longer if we can reverse aging but how soon! My timeline is latest by 2040!

Stopping aging is the first step. The second is eliminating it entirely. That's all.

biotech is starting to move like AI did 3 years ago and the smart money is moving fast - Brian Armstrong's NewLimit just hit a $3.1B valuation - Jeff Bezos put $3B behind Altos Labs - Demis Hassabis raised $2.1B for Isomorphic Labs - Anthropic acquired Coefficient Bio for $400M - NVIDIA is backing companies building programmable biology - longevity biotech raised $3.74B in Q1 2026 alone. 56% ahead of Q1 2025. the interesting part is not the funding it is what the funding is chasing for the first time in history we are building tools that can read, model, and modify human biology at scale Eli Lilly became one of the largest companies on earth from a single peptide category imagine what happens when the entire stack becomes programmable the smart money is not speculating anymore it is positioning Superhuman Fund II is open for whoever wants in bio/acc

“…randomized phase 3 trial published in the New England Journal of Medicine, daraxonrasib gave a median overall survival of 13.2 months versus 6.7 months for standard chemotherapy.”

SITUATION DETECTED: Revolution Medicines’ oral cancer drug daraxonrasib nearly doubled survival rates for patients with metastatic pancreatic cancer in a Phase 3 trial.

Anktiva's approval is solid for BCG-unresponsive bladder cancer: ~70% complete responses in trials, many durable (up to 4+ years), via IL-15 superagonist boosting NK cells and memory T cells. Real win for that patient group. The "most important longevity drug" framing from Soon-Shiong is speculative hype. It targets immunosenescence mechanistically, but zero dedicated longevity trials in healthy people. No evidence it extends healthspan or prevents aging/cancer broadly. FDA has even warned on overclaims. Promising immunotherapy direction—watch broader trials. Not a quiet longevity revolution yet.

The FDA just approved a longevity drug -- and almost nobody noticed. Anktiva (an IL-15 superagonist) was greenlit for bladder cancer. But the scientist behind it, Patrick Soon-Shiong, calls it the most important longevity drug of the decade. (1/5)

Are you starting to see it yet? We will have one-shot cures and preventions for all diseases by 2030. AI will reach maximum intelligence and ability by 2030. We will be at the end state of technology by 2030.

I can clearly see now the path to longevity escape velocity Ray Kurzweil has laid out All disease/aging is just proteomic dysfunction and we're going to completely fix that and abstract it away in the coming 5-10 years Biology is going to eclipse every other platform